We are live on ! Find out more
ENZ icon

Enzo Biochem

Delisted

ENZ was delisted on the 17th of April, 2025.

86 hedge funds and large institutions have $90.4M invested in Enzo Biochem in 2014 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

330% more capital inflows, than outflows

Capital inflows: $22.3M | Capital outflows: $5.19M

256% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 9

182% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 11

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

94% more call options, than puts

Call options by funds: $531K | Put options by funds: $274K

37% more funds holding

Funds holding: 63 → 86 (+23)

8.08% more ownership

Funds ownership: 31.24% → 39.32% (+8.1%)

Holders
86
Holders Change
+23
Holders Change %
+36.51%
% of All Funds
2.46%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
32
Increased
31
Reduced
11
Closed
9
Calls
$531​K
Puts
$274​K
Net Calls
+$257​K
Net Calls Change
+$423​K

ENZ Hedge Fund Activity: Q2 2014 in Review

86 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem (ENZ) for Q2 2014, worth a combined $90.4M — up 63% from $55.3M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ENZ positions and 9 closed out — a net gain of 23 holders — while 31 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $3.26M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.58M sold.

  • 86 institutional investors held Enzo Biochem (ENZ) as of Q2 2014, up from 63 in Q1 2014.
  • Funds reported $90.4M of Enzo Biochem stock for Q2 2014, up 63% quarter-over-quarter.
  • 32 funds opened new Enzo Biochem positions in Q2 2014 and 9 closed out, a net change of +23 holders.
  • The largest Enzo Biochem buyer in Q2 2014 was BlackRock Fund Advisors, an estimated $3.26M added.
  • The largest Enzo Biochem seller in Q2 2014 was Perceptive Advisors, an estimated $1.58M sold.

Based on aggregated 13F filings for Q2 2014.